Adial Pharmaceuticals - As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting - ADIL News | RalliesAdial Pharmaceuticals - As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting
A
ADIL• Adial Pharmaceuticals says CEO and CFO changes are anticipated
- Adial Pharmaceuticals, as of Aug. 10, anticipates termination of CEO Cary Claiborne after the 2026 annual meeting - SEC filing
- Adial Pharmaceuticals anticipates Matthew Davidson to be appointed president and CEO - SEC filing
- Adial Pharmaceuticals anticipates termination of CFO Vinay Shah after the 2026 annual meeting - SEC filing
- Adial Pharmaceuticals anticipates board changes and legacy member resignations after stockholder approval - SEC filing
WDAY
•
